title: Calcium channel subtypes for cholinergic and nonadrenergic noncholinergic neurotransmission in isolated guinea pig trachea.
abstract: The Ca(2+) channel subtypes in the neurotransmission of isolated guinea pig trachea were elucidated by monitoring the effects of specific Ca(2+) channel blockers on cholinergic contractions and nonadrenergic noncholinergic (NANC) relaxation elicited by electrical field stimulation (EFS). In isolated guinea pig trachea, cholinergic contractile responses to low- and high-frequency EFS were inhibited by the selective N-type calcium channel blocker, ω-conotoxin MVIIA. ω-Agatoxin IVA (a selective P-type blocker), ω-conotoxin MVIIC (a nonselective N-, Q-, and P-type blocker), and nifedipine (a selective L-type blocker) were ineffective, whereas Ni(2+) (a T- and R-type blocker) facilitated cholinergic contractions and produced a late contracture when its concentration exceeded 30 μM. The more the concentration of Ni(2+) increased, the greater the number of incidences and the late contracture areas which occurred. Late contracture did not seem to be due to the effects of acetylcholine, tachykinins, or other polypeptides, but disappeared in the absence of indomethacin. The NANC relaxant responses elicited by the low- and high-frequency EFS were inhibited by ω-conotoxin MVIIA or Ni(2+), but unaffected by ω-Agatoxin IVA, ω-conotoxin MVIIC, and nifedipine. In the absence of indomethacin, Ni(2+) did not alter the ω-conotoxin MVIIA (100 nM)-resistant component of cholinergic contraction, but significantly further inhibited that of NANC relaxation. These results suggest that in isolated guinea pig trachea, cholinergic contraction is regulated by N-type calcium channels which may mask T- and R-type calcium channels and may be co-modulated by both, while NANC relaxation is mainly and independently controlled by N-, T-, and R-type calcium channels.
authors.affiliation: Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
authors.forename: Chung-Hung
authors.initials: CH
authors.lastname: Shih
authors.forename: Hsin-Te
authors.initials: HT
authors.lastname: Hsu
authors.forename: Kuo-Hsien
authors.initials: KH
authors.lastname: Wang
authors.forename: Chih-Hsieh
authors.initials: CH
authors.lastname: Shih
authors.forename: Wun-Chang
authors.initials: WC
authors.lastname: Ko
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015220:Calcium Channels / Q000502:physiology*; D020864:Calcium Channels, N-Type / Q000502:physiology; D020908:Calcium Channels, R-Type / Q000502:physiology; D020747:Calcium Channels, T-Type / Q000502:physiology; D018678:Cholinergic Agents / Q000494:pharmacology*; D004558:Electric Stimulation; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009543:Nifedipine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D014132:Trachea / Q000187:drug effects* / Q000502:physiology; D020867:omega-Agatoxin IVA / Q000494:pharmacology; D020866:omega-Conotoxin GVIA / Q000494:pharmacology; D020960:omega-Conotoxins / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020864:Calcium Channels, N-Type; D020908:Calcium Channels, R-Type; D020747:Calcium Channels, T-Type; D018678:Cholinergic Agents; D020867:omega-Agatoxin IVA; D020960:omega-Conotoxins; C075851:omega-conotoxin-MVIIC; D020866:omega-Conotoxin GVIA; D009543:Nifedipine; D000109:Acetylcholine
references.citation: Curr Opin Neurobiol. 1992 Jun;2(3):247-53
references.pmid: 1322749
references.citation: Neuroscience. 1996 Feb;70(3):817-24
references.pmid: 9045091
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L523-34
references.pmid: 18203813
references.citation: Nature. 1992 Feb 27;355(6363):827-9
references.pmid: 1311418
references.citation: J Physiol. 1987 Dec;394:149-72
references.pmid: 2451016
references.citation: J Neurosci. 1996 Jul 1;16(13):4155-61
references.pmid: 8753877
references.citation: Nature. 1997 Oct 23;389(6653):816-24
references.pmid: 9349813
references.citation: J Physiol. 1993 Jan;460:719-39
references.pmid: 8487216
references.citation: Br J Pharmacol. 1991 Jan;102(1):91-4
references.pmid: 2043935
references.citation: Proc Natl Acad Sci U S A. 1980 Mar;77(3):1651-5
references.pmid: 6103537
references.citation: Regul Pept. 1985 Dec;13(1):1-19
references.pmid: 2418471
references.citation: Neuron. 1993 Aug;11(2):291-303
references.pmid: 8394721
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):107-13
references.pmid: 2460772
references.citation: Neuron. 1992 Jul;9(1):69-77
references.pmid: 1352986
references.citation: Neurogastroenterol Motil. 2003 Jun;15(3):299-306
references.pmid: 12787339
references.citation: Br J Pharmacol. 1990 Oct;101(2):437-47
references.pmid: 2175236
references.citation: Can J Physiol Pharmacol. 1986 Aug;64(8):1096-103
references.pmid: 3098395
references.citation: Proc Natl Acad Sci U S A. 1987 Jun;84(12):4327-31
references.pmid: 2438698
references.citation: FASEB J. 1991 Sep;5(12):2677-83
references.pmid: 1655547
references.citation: Annu Rev Biochem. 1994;63:823-67
references.pmid: 7979255
references.citation: J Pharmacol Exp Ther. 1995 Apr;273(1):248-56
references.pmid: 7714772
references.citation: Br J Pharmacol. 1993 Dec;110(4):1285-90
references.pmid: 8306066
references.citation: Biochem Soc Trans. 1993 May;21(2):395-401
references.pmid: 8103003
references.citation: Nature. 1993 Jun 3;363(6428):455-8
references.pmid: 8389006
references.citation: J Clin Endocrinol Metab. 2005 Apr;90(4):2192-7
references.pmid: 15671094
references.citation: Br J Pharmacol. 1990 Aug;100(4):663-4
references.pmid: 2207492
references.citation: Science. 1994 Apr 1;264(5155):107-11
references.pmid: 7832825
references.citation: Eur J Pharmacol. 1997 Feb 26;321(2):217-23
references.pmid: 9063691
references.citation: Br J Pharmacol. 1995 Sep;116(1):1595-8
references.pmid: 8564224
references.citation: Annu Rev Pharmacol Toxicol. 1992;32:399-421
references.pmid: 1318672
references.citation: Am J Physiol. 1973 May;224(5):1072-80
references.pmid: 4144764
references.citation: Br J Pharmacol. 1996 Jun;118(3):797-803
references.pmid: 8762110
references.citation: Clin Exp Pharmacol Physiol. 1989 Apr;16(4):333-9
references.pmid: 2568204
references.citation: Proc Natl Acad Sci U S A. 1984 Sep;81(18):5871-5
references.pmid: 6091117
references.citation: Neuropharmacology. 1993 Nov;32(11):1075-88
references.pmid: 8107963
references.citation: J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb;50(2):374-82
references.pmid: 6259102
references.citation: Prostaglandins. 1987 May;33(5):651-61
references.pmid: 3588974
references.citation: Br J Pharmacol. 1997 Feb;120(3):393-8
references.pmid: 9031741
references.citation: Pflugers Arch. 1995 Apr;429(6):873-5
references.pmid: 7603842
references.citation: J Physiol. 1996 Aug 1;494 ( Pt 3):687-95
references.pmid: 8865066
references.citation: Eur J Pharmacol. 1994 Aug 11;261(1-2):79-84
references.pmid: 8001657
references.citation: Neuroscience. 1979;4(11):1539-59
references.pmid: 390416
references.citation: Br J Pharmacol. 1996 Sep;119(1):49-56
references.pmid: 8872356
references.citation: Mol Pharmacol. 1995 Feb;47(2):348-53
references.pmid: 7870043
references.citation: J Physiol. 1994 Nov 1;480 ( Pt 3):613-25
references.pmid: 7869272
references.citation: J Physiol. 1987 Feb;383:231-49
references.pmid: 2443646
references.citation: J Clin Invest. 1980 Feb;65(2):314-20
references.pmid: 7356681
references.citation: Physiol Rev. 1995 Apr;75(2):277-322
references.pmid: 7724664
references.citation: Science. 1992 May 1;256(5057):677-9
references.pmid: 1350109
references.citation: J Physiol. 1995 Jan 15;482 ( Pt 2):283-90
references.pmid: 7714822
references.citation: Life Sci. 1997;60(12):883-92
references.pmid: 9061045
references.citation: Br J Pharmacol. 1995 Sep;116(1):1577-82
references.pmid: 8564221
references.citation: J Physiol. 1993 Nov;471:25-40
references.pmid: 7907144
references.citation: Br J Pharmacol. 1999 Sep;128(1):262-8
references.pmid: 10498861
references.citation: Neuron. 1992 Jul;9(1):85-95
references.pmid: 1321648
references.citation: J Physiol. 1988 Jan;395:233-53
references.pmid: 2457676
references.citation: Eur J Pharmacol. 1993 Feb 9;231(2):197-202
references.pmid: 7681004
references.citation: Science. 1988 Jan 1;239(4835):57-61
references.pmid: 2447647
references.citation: Eur J Pharmacol. 1994 Jun 2;258(1-2):155-8
references.pmid: 7925595